Neurizon’s ALS drug regimen cleared for launch in Healey platform trial
The Healey ALS Platform Trial is a multicenter, double-blind, placebo-controlled
The Healey ALS Platform Trial is a multicenter, double-blind, placebo-controlled
This strategic investment aims to bolster the company's position as a global leader in Vitamin D3 manufacturing
The collaboration will establish the MUMPMP–Agilent BioDiscovery Hub
The center will offer training to super-specialist doctors and healthcare professionals in various fields
Granules Consumer Health serves as Granules’ front-end division for OTC products in the US
Growing patent filings and tier-2 innovators reflect expanding national research base
Sommaplast’s portfolio includes closures, droppers, dispensers and dosing cups, supporting a broad range of oral dosing applications
This is the first time in history that an NDA for a New Chemical Entity (NCE) from an Indian pharmaceutical company has been filed and accepted by the USFDA
The audit was completed with zero critical and zero major observations
Subscribe To Our Newsletter & Stay Updated